Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

(2018) Craig M McDonald et al.   LANCET

Evidence-based care in Duchenne muscular dystrophy

(2018) Craig M McDonald et al.   LANCET NEUROLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management

(2018) David J Birnkrant et al.   LANCET NEUROLOGY

Deflazacort vs prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post hoc analysis from the ACT DMD trial

(2018) Perry B Shieh et al.   MUSCLE & NERVE

Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop

(2018) Leanne M. Ward et al.   NEUROMUSCULAR DISORDERS

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment

(2017) Brenda L. Wong et al.   JOURNAL OF PEDIATRICS

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

(2017) S. Ryder et al.   Orphanet Journal of Rare Diseases

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy

(2016) Jerry R. Mendell et al.   ANNALS OF NEUROLOGY

A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy

(2016) Makiko Nakamura et al.   International Heart Journal

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

(2016) Robert C. Griggs et al.   NEUROLOGY

Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy

(2016) David Gloss et al.   NEUROLOGY

Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study

(2015) Luca Bello et al.   NEUROLOGY

Trends With Corticosteroid Use in Males With Duchenne Muscular Dystrophy Born 1982-2001

(2014) Deborah J. Fox et al.   JOURNAL OF CHILD NEUROLOGY

Duchenne and Becker Muscular Dystrophies

(2014) Kevin M. Flanigan   NEUROLOGIC CLINICS

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice

(2013) Robert C. Griggs et al.   MUSCLE & NERVE

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

(2013) Craig M. McDonald et al.   MUSCLE & NERVE

The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe

(2013) Erik K. Henricson et al.   MUSCLE & NERVE

Implications of glucocorticoid therapy in idiopathic inflammatory myopathies

(2012) Beatriz Y. Hanaoka et al.   Nature Reviews Rheumatology

Mechanisms of Muscle Atrophy Induced by Glucocorticoids

(2009) O. Schakman et al.   HORMONE RESEARCH

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Disability and survival in Duchenne muscular dystrophy

(2008) M Kohler et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY